Supreme Court Holds FCA Scienter Includes Subjective Beliefs, Revives Drug Pricing Fraud Actions
- June 02, 2023
The U.S. Supreme Court issued June 1 a much-anticipated ruling that vacates a pair of Seventh Circuit decisions rejecting qui tam actions under the False Claims Act (FCA) for failing to establish scienter under the statute.
ARTICLE TAGS
You must be logged in to access this content.